How Subchronic and Chronic Health Effects can be Neglected for GMOs, Pesticides or Chemicals
Year: 2009
Type: article
Abstract: Chronic health effects are increasing in the world such as cancers, hormonal, reproductive, nervous, or immune diseases, even in young people. During regulatory toxicological subchronic tests to prevent these on mammalian health, prior commercialization of chemicals, including pesticides and drugs, or GMOs, some statistically significant findings may be revealed. This discussion is about the need to investigate the relevant criteria to consider those as biologically significant. The sex differences and the non linear dose or time related effects should be considered in contrast to the claims of a Monsanto-supported expert panel about a GMO, the MON 863 Bt maize, but also for pesticides or drugs, in particular to reveal hormone-dependent diseases and first signs of toxicities.
DOI: 10.7150/ijbs.5.438
Institutions: Université de Caen Normandie, Laboratoire d'Informatique, du Traitement de l'Information et des Systèmes, Université de Rouen Normandie, Centre National de la Recherche Scientifique, Université de Montpellier, Hôpital Lapeyronie, Hôpital Arnaud de Villeneuve, Institut de Génétique Humaine, University of Florence, New Zealand Institute for Public Health and Forensic Science, Guy's Hospital, King's College London
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W2138322647